HEARTFLOW
HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe and Japan. For more information, visit www.heartflow.com.
HEARTFLOW
Industry:
Artificial Intelligence Biotechnology Health Care Health Diagnostics Medical Software
Founded:
2007-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.heartflow.com
Total Employee:
251+
Status:
Active
Contact:
650-241-1221
Email Addresses:
[email protected]
Total Funding:
577.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Domain Not Resolving Amazon IPv6 Google Apps For Business GoDaddy DNS
Similar Organizations
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Medicago
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
North Beach Vascular & Aesthetics
North Beach Vascular & Aesthetics is a medical company that provides diagnosis, medical treatment, and cosmetic vascular disorders.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series E - HeartFlow
Rancilio Cube
Rancilio Cube investment in Series E - HeartFlow
Martis Capital
Martis Capital investment in Series E - HeartFlow
Baillie Gifford
Baillie Gifford investment in Series E - HeartFlow
Panorama Point Partners
Panorama Point Partners investment in Series D - HeartFlow
Lifeforce Capital
Lifeforce Capital investment in Series C - HeartFlow
Capricorn Investment Group
Capricorn Investment Group investment in Series C - HeartFlow
HealthCor Partners
HealthCor Partners investment in Seed Round - HeartFlow
U.S. Venture Partners
U.S. Venture Partners investment in Seed Round - HeartFlow
Emergent Medical Partners
Emergent Medical Partners investment in Seed Round - HeartFlow
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-01 | HeartFlow announces new CEO |
| 2021-08-04 | HeartFlow appoints former Medtronic executive as COO |
Official Site Inspections
http://www.heartflow.com Semrush global rank: 2.66 M Semrush visits lastest month: 6.34 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HeartFlow"
HeartFlow - Crunchbase Company Profile & Funding
HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease. View contacts for HeartFlow to access new leads and connect with decision-makers. HeartFlow focuses on …See details»
Management Team - HeartFlow
He joined HeartFlow in 2010 and held various product, technology, and commercial leadership roles to build HeartFlow’s product and service. Previously, Tim led design engineering at Cameron Health (acquired by Boston Scientific) …See details»
Our Story - HeartFlow
HeartFlow is a medical technology company revolutionizing precision heart care. There is no company in the world doing what we do—combining decades of human ingenuity and …See details»
Home - HeartFlow
HeartFlow and the HeartFlow logo are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc.See details»
HeartFlow - Bain Capital Life Sciences
HeartFlow is transforming precision coronary care with the only AI-powered non-invasive integrated heart care solution across the CCTA pathway. As the pioneer of FFRCT, which is …See details»
Revolutionizing Precision Heart Care - HeartFlow
About HeartFlow » 96% of people in the US have insurance coverage for HeartFlow » 90,000+ patients have received a HeartFlow Analysis » Adopted by more than 400 hospitals worldwide, …See details»
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes …
Apr 6, 2023 Financing will further drive commercial scale for HeartFlow’s AI-enabled portfolio of precision heart care productsMOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- …See details»
HeartFlow, the Leader in Precision Heart Care, …
Jul 15, 2021 HeartFlow’s core product, the HeartFlow FFR CT Analysis, is a non-invasive cardiac test for stable symptomatic patients with coronary artery disease (CAD), the most common type of cardiovascular ...See details»
HeartFlow and MedAxiom Announce Collaboration to Improve …
May 5, 2021 About the HeartFlow FFRct Analysis. ... MedAxiom is transforming cardiovascular care by combining the knowledge and power of 425+ cardiovascular organization members, …See details»
HeartFlow, Leader in Revolutionizing Precision Heart Care,
Apr 6, 2023 MOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million …See details»
HeartFlow Plaque Analysis
Nov 24, 2024 As part of the HeartFlow ONE precision coronary artery disease (CAD) management solution, HeartFlow Plaque Analysis provides more complete data on the type of …See details»
HeartFlow Initiates DECIDE Registry to Evaluate Utility of …
Mar 26, 2024 HeartFlow Plaque Analysis is the only FDA cleared AI-enabled plaque quantification tool validated in a prospective international trial against the gold standard of …See details»
HeartFlow Analysis is First AI-Enabled Technology to be
Oct 28, 2021 HeartFlow’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as …See details»
HeartFlow Achieves Landmark Milestone of 250,000 Patients …
Jan 3, 2024 This patient milestone and the recent launch of Plaque Analysis and RoadMapâ„¢ Analysis further solidify HeartFlow as a pioneer in AI-enabled CAD diagnosticsMOUNTAIN …See details»
HeartFlow: A Deep Dive - The Motley Fool
HeartFlow is a software company that is helping to make those coronary CTA scans which are used in a minority of cases even better. Lewis: I think as is often the case with med tech …See details»
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes …
Apr 6, 2023 HeartFlow is the global leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced AI technology.See details»
New 10-Year Data Demonstrate Superiority of the HeartFlow …
May 18, 2021 About HeartFlow, Inc. HeartFlow, Inc. is a leader in revolutionizing precision heartcare, uniquely combining human ingenuity with advanced technology. Our non-invasive …See details»
HeartFlow Information Kit
The HeartFlow Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease. The information provided by the HeartFlow …See details»
HeartFlow Analysis is First AI-Enabled Technology to be …
Oct 28, 2021 REDWOOD CITY, Calif. – October 28, 2021 — HeartFlow, Inc., the leader in revolutionizing precision heart care, today welcomed new clinical practice guidelines from the …See details»